Primary diffuse large B-cell lymphoma of the uterus: A SEER database analysis

por Ensor, Allyne M., Sanchez, Cesar Gentille, Ensor, Joe E., Anand, Kartik
Publicado 2021

Outcomes and prognostic contributors in patients with KRAS mutated non-small cell pulmonary adenocarcinomas: a single institution experience

por Burns, Ethan A., Ensor, Joe E., Hsu, Jim, Thomas, Jessica S., Olsen, Randall J., Bernicker, Eric H.
Publicado 2021

A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2‐Negative Breast Cancer

por Lim, Bora, Song, Juhee, Ibrahim, Nuhad K., Koenig, Kimberly B., Chavez‐MacGregor, Mariana, Ensor, Joe E., Gomez, Jill Schwartz, Krishnamurthy, Savitri, Caudle, Abigail S., Shaitelman, Simona F., Whitman, Gary J., Valero, Vicente
Publicado 2020

Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic

por Darcourt, Jorge G., Aparicio, Kalia, Dorsey, Phillip M., Ensor, Joe E., Zsigmond, Eva M., Wong, Stephen T., Ezeana, Chika F., Puppala, Mamta, Heyne, Kirk E., Geyer, Charles E., Phillips, Robert A., Schwartz, Roberta L., Chang, Jenny C.
Publicado 2021

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Cente...

por Fouad, Tamer M., Ueno, Naoto T., Yu, Robert K., Ensor, Joe E., Alvarez, Ricardo H., Krishnamurthy, Savitri, Lucci, Anthony, Reuben, James M., Yang, Wei, Willey, Jie S., Valero, Vicente, Bondy, Melissa L., Cristofinalli, Massimo, Shete, Sanjay, Woodward, Wendy A., El-Zein, Randa
Publicado 2018

Role of RPL39 in Metaplastic Breast Cancer

por Dave, Bhuvanesh, Gonzalez, Daniel D., Liu, Zhi-Bin, Li, Xiaoxian, Wong, Helen, Granados, Sergio, Ezzedine, Nadeer E., Sieglaff, Douglas H., Ensor, Joe E., Miller, Kathy D., Radovich, Milan, KarinaEtrovic, Agda, Gross, Steven S., Elemento, Olivier, Mills, Gordon B., Gilcrease, Michael Z., Chang, Jenny C.
Publicado 2017

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive brea...

por Patel, Tejal A., Ensor, Joe E., Creamer, Sarah L., Boone, Toniva, Rodriguez, Angel A., Niravath, Poly A., Darcourt, Jorge G., Meisel, Jane L., Li, Xiaoxian, Zhao, Jing, Kuhn, John G., Rosato, Roberto R., Qian, Wei, Belcheva, Anna, Schwartz, Mary R., Kaklamani, Virginia G., Chang, Jenny C.
Publicado 2019

HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway

por Liu, Yi, Choi, Dong Soon, Sheng, Jianting, Ensor, Joe E., Liang, Diana Hwang, Rodriguez-Aguayo, Cristian, Polley, Amanda, Benz, Steve, Elemento, Olivier, Verma, Akanksha, Cong, Yang, Wong, Helen, Qian, Wei, Li, Zheng, Granados-Principal, Sergio, Lopez-Berestein, Gabriel, Landis, Melissa D., Rosato, Roberto R., Dave, Bhuvanesh, Wong, Stephen, Marchetti, Dario, Sood, Anil K., Chang, Jenny C.
Publicado 2017